Stevanato Group (STVN) Competitors €19.59 +0.58 (+3.05%) (As of 11/1/2024 08:57 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends STVN vs. SOLV, SNN, PEN, BLCO, GKOS, INSP, TMDX, AXNX, PRCT, and NVSTShould you be buying Stevanato Group stock or one of its competitors? The main competitors of Stevanato Group include Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Bausch + Lomb (BLCO), Glaukos (GKOS), Inspire Medical Systems (INSP), TransMedics Group (TMDX), Axonics (AXNX), PROCEPT BioRobotics (PRCT), and Envista (NVST). These companies are all part of the "medical equipment" industry. Stevanato Group vs. Solventum Smith & Nephew Penumbra Bausch + Lomb Glaukos Inspire Medical Systems TransMedics Group Axonics PROCEPT BioRobotics Envista Stevanato Group (NYSE:STVN) and Solventum (NYSE:SOLV) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, dividends, earnings and community ranking. Is STVN or SOLV more profitable? Stevanato Group has a net margin of 11.27% compared to Solventum's net margin of 0.00%. Stevanato Group's return on equity of 10.89% beat Solventum's return on equity.Company Net Margins Return on Equity Return on Assets Stevanato Group11.27% 10.89% 6.33% Solventum N/A N/A N/A Which has better valuation and earnings, STVN or SOLV? Stevanato Group has higher revenue and earnings than Solventum. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStevanato Group$1.17BN/A$157.62M$0.5039.18SolventumN/AN/AN/AN/AN/A Do analysts rate STVN or SOLV? Solventum has a consensus target price of $64.33, suggesting a potential downside of 11.22%. Given Solventum's higher possible upside, analysts plainly believe Solventum is more favorable than Stevanato Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Stevanato Group 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75Solventum 1 Sell rating(s) 8 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the MarketBeat Community prefer STVN or SOLV? Stevanato Group received 26 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 62.79% of users gave Stevanato Group an outperform vote while only 6.67% of users gave Solventum an outperform vote. CompanyUnderperformOutperformStevanato GroupOutperform Votes2762.79% Underperform Votes1637.21% SolventumOutperform Votes16.67%Underperform Votes1493.33% Does the media refer more to STVN or SOLV? In the previous week, Solventum had 10 more articles in the media than Stevanato Group. MarketBeat recorded 11 mentions for Solventum and 1 mentions for Stevanato Group. Solventum's average media sentiment score of 0.86 beat Stevanato Group's score of 0.00 indicating that Solventum is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stevanato Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Solventum 6 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryStevanato Group beats Solventum on 8 of the 11 factors compared between the two stocks. Ad Crypto 101 MediaMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…All you have to do is claim your free ticket to the event now… Get Stevanato Group News Delivered to You Automatically Sign up to receive the latest news and ratings for STVN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STVN vs. The Competition Export to ExcelMetricStevanato GroupSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket CapN/A$4.45B$5.40B$19.26BDividend YieldN/A42.37%5.15%3.54%P/E Ratio39.1837.84113.7641.40Price / SalesN/A64.751,483.0414.66Price / Cash22.2649.2739.7120.84Price / Book4.724.214.665.39Net Income$157.62M$11.52M$119.06M$985.39M7 Day Performance13.43%1.05%0.79%-0.70%1 Month Performance-2.05%0.94%5.65%-0.97%1 Year Performance-24.77%39.40%36.80%25.06% Stevanato Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STVNStevanato Group1.0467 of 5 stars€19.59+3.1%N/A-23.9%$0.00$1.17B39.185,635Upcoming EarningsSOLVSolventum1.612 of 5 stars$73.190.0%$64.33-12.1%N/A$12.64B$8.25B0.0022,000Upcoming EarningsSNNSmith & Nephew1.9055 of 5 stars$28.37-3.8%N/A+13.1%$12.40B$5.64B13.7718,452Analyst DowngradeNews CoverageGap DownPENPenumbra3.9 of 5 stars$204.71-0.9%$220.17+7.6%+20.2%$7.94B$1.13B602.094,200Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageBLCOBausch + Lomb2.3267 of 5 stars$20.46+1.4%$20.27-0.9%+24.2%$7.20B$4.50B-15.7413,300Analyst ForecastShort Interest ↑Analyst RevisionNews CoverageGKOSGlaukos3.6575 of 5 stars$130.59+0.1%$130.45-0.1%+89.5%$6.58B$341.73M-40.06780Upcoming EarningsInsider SellingINSPInspire Medical Systems4.7122 of 5 stars$195.20-0.1%$219.58+12.5%+22.0%$5.82B$624.80M1,084.441,011Upcoming EarningsNews CoverageTMDXTransMedics Group4.2511 of 5 stars$125.17+2.6%$174.30+39.3%+116.6%$4.18B$241.62M3,129.25210Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageAXNXAxonics3.7971 of 5 stars$70.23-0.1%$69.57-0.9%+35.9%$3.58B$408.81M-1,755.31610Upcoming EarningsShort Interest ↓Positive NewsPRCTPROCEPT BioRobotics1.3718 of 5 stars$68.77+2.9%$86.40+25.6%+235.0%$3.54B$176.58M-33.38626Earnings ReportAnalyst ForecastInsider SellingAnalyst RevisionNews CoverageHigh Trading VolumeNVSTEnvista4.3067 of 5 stars$18.89-0.7%$19.88+5.2%-8.9%$3.25B$2.53B-2.4512,800Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage Related Companies and Tools Related Companies SOLV Alternatives SNN Alternatives PEN Alternatives BLCO Alternatives GKOS Alternatives INSP Alternatives TMDX Alternatives AXNX Alternatives PRCT Alternatives NVST Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:STVN) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stevanato Group S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stevanato Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.